Cargando…

Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: Retrospective analysis results in an unselected single-center cohort

Bisphosphonates are the gold standard for preventing skeletal-related events in patients with bone-metastatic cancer and have been investigated for reducing cancer treatment-induced bone loss. Evidence suggests bisphosphonates also offer anticancer benefits in adjuvant and advanced cancer settings....

Descripción completa

Detalles Bibliográficos
Autores principales: Hadji, Peyman, Frank, Matthias, Jakob, Andreas, Siebers, Jan Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723356/
https://www.ncbi.nlm.nih.gov/pubmed/26909267
http://dx.doi.org/10.1016/j.jbo.2013.01.001